Recombinant urate oxidase
Term · Oncology and biomedicine · MLC-T-ONC-007261
A drug used to treat high levels of uric acid in the blood of adults and children with leukemia, lymphoma, or other types of cancer who are receiving certain types of anticancer therapy. Uric acid is a natural substance that can build up in the blood as tumors break down. Recombinant urate oxidase helps break down and remove uric acid from the body. It is a type of recombinant enzyme and a type of urate-lowering drug. Also called Elitek and rasburicase.
| Identifier | MLC-T-ONC-007261 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Elitek; rasburicase |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007261",
"term": "Recombinant urate oxidase",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat high levels of uric acid in the blood of adults and children with leukemia, lymphoma, or other types of cancer who are receiving certain types of anticancer therapy. Uric acid is a natural substance that can build up in the blood as tumors break down. Recombinant urate oxidase helps break down and remove uric acid from the body. It is a type of recombinant enzyme and a type of urate-lowering drug. Also called Elitek and rasburicase.",
"synonyms": [
"Elitek",
"rasburicase"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-urate-oxidase/"
}
Record 14,213 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.